Nuvation Bio Inc Class A (NUVB)
$4.76 -0.21% Close Oct 30, 2026 Live
Nuvation Bio stock today
Nuvation Bio closed at $4.76 on October 30, 2026, down 0.21% on the day. Over the past year it returned -7.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.66 billion.
$4.00$6.00$8.00
NovJan 2026MarMayJulSep
| Period | NUVB | S&P 500 (SPY) |
|---|---|---|
| 1 month | -15.0% | -0.9% |
| 3 months | -29.0% | +2.1% |
| Year to date | -46.9% | +11.7% |
| 1 year | -7.6% | +12.4% |
| 3 years | +376.0% | +88.5% |
| 5 years | -48.1% | +76.0% |
Key statistics
- Market value
- $1.66B
- Price / sales
- 9.8
- 52-week range
- $4.05 to $9.54
- Next report
- Nov 4, 2026
About Nuvation Bio
Develops monoclonal antibody therapies for oncology and immunology conditions.
Sector: Health Care
More on Nuvation Bio
- Returns: what $1,000 became$1,000 five years ago is $519.08 today
No forecast, no recommendation. This page describes Nuvation Bio Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.